AxoGen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.24 billion, with shareholders equity totaling $244.81 .
The company employs approximately 368 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, AxoGen Inc. reported $238.10 in revenue, generating net income of $-31.45 .
Key financial metrics include a P/E ratio of -71.10, a price-to-book (P/B) ratio of 9.13, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AXGN.